Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
Targeted Treatment Options for Patients With AML and FLT3 or IDH1/2 Mutations
Manage episode 317178023 series 3256997
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses targeted therapy with FLT3 and IDH1/2 inhibitors in AML, with a focus on the nursing perspective. Topics include:
- Approved and emerging treatment options for FLT3-mutated AML
- Management of adverse events associated with FLT3 inhibitors
- Therapies for IDH1- and IDH2-mutated AML
- Identifying and managing differentiation syndrome associated with IDH1/2 inhibitors
Presenters:
Sarah M. Tinsley, PhD, APRN, AOCN
Nurse Practitioner
Courtesy Assistant Professor
Department of Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida
170 tập
Manage episode 317178023 series 3256997
In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses targeted therapy with FLT3 and IDH1/2 inhibitors in AML, with a focus on the nursing perspective. Topics include:
- Approved and emerging treatment options for FLT3-mutated AML
- Management of adverse events associated with FLT3 inhibitors
- Therapies for IDH1- and IDH2-mutated AML
- Identifying and managing differentiation syndrome associated with IDH1/2 inhibitors
Presenters:
Sarah M. Tinsley, PhD, APRN, AOCN
Nurse Practitioner
Courtesy Assistant Professor
Department of Malignant Hematology
Moffitt Cancer Center
University of South Florida
Tampa, Florida
170 tập
Tất cả các tập
×Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.